Figure 4
From: IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment
Follow-up levels of IL-23 were higher in patients with an unfavourable BILAG response. (a) Serum levels of IL-23 in patients at baseline and follow-up in patients and levels in controls (medians 5.5, 3.3 and 0.7 pg/ml respectively). (b) Levels of of IL-23 in all patients were significantly higher in BILAG non-responder (NR) patients vs. partial- (PR) and complete responders (CR), this was most pronounced in the group of patients with WHO class V at follow-up as shown in (c). Boxes limits show 25th to 75th percentile and median values are marked inside the boxes.